> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Philips Recalls Tack Endovascular Device
- URL: https://www.fdaweb.com/philips-recalls-tack-endovascular-device/
- Published: 2025-03-03T12:00:00.000Z
- Updated: 2026-09-14T14:54:22.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5158752

Philips is recalling (Class 1) its Tack Endovascular Systems due to customer complaints, including events where additional interventions were required to retrieve or remove the implant. A [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/endovascular-system-recall-philips-removes-and-discontinues-distribution-tack-endovascular-system?utm%5Fmedium=email&utm%5Fsource=govdelivery) recommends that customers should stop using the device immediately. Philips says it will no longer distribute the system for use.

“The use of affected product may cause serious adverse health consequences, including short-term risks of partial or completely blocked blood flow (occlusion), holes or tears in the inner lining of the artery (dissection) through the entire artery wall (perforation), as well as long term risks such as pain, tissue loss, re-narrowing of a widened or stented vessel (restenosis), the need for bypass surgery, amputation, and death,” the notice says. To date, there have been 20 reported injuries, and no reports of death.

The device is used to treat dissection of the blood vessels after they are widened using a balloon or stent (angioplasty). It attaches damaged tissue to the inner lining of the blood vessel to repair the dissection, the notice says.